EMA issues positive opinion on Hansa’s application for orphan drug designation of recombinant IdeS
Home  »  Community News  »  EMA issues positive opinion on Hansa’s application for orphan drug designation of recombinant IdeS
Dec
19
ragupathyrenganathan
EMA issues positive opinion on Hansa’s application for orphan drug designation of recombinant IdeS
Drug Discovery, Pharma News
0